Orbit Discovery is heading to Vienna for BioEurope 2025!
We’re excited to connect and share how Orbit’s peptide discovery platform is advancing the next generation of targeted delivery and functional screening.
Our unique ability to screen for function — identifying novel agonists, antagonists, and other modulators — alongside precision targeting enables companies to find peptides that don’t just bind, but work. Neil Butt (Orbit CEO) and Simon Bushell (External Innovation and BD) will be there to discuss how Orbit is helping biotechs and pharma accelerate discovery and de-risk development of peptide-based therapeutics.
If you’re attending and would like to connect, let’s set up a time to meet.